Practice

RAS Prelims MCQ Practice

9,654 RAS Prelims practice MCQs with the correct answer and a clear explanation for each. Filter by subject and chapter.

Practice questions based on the RPSC RAS Prelims syllabus. They follow the exam pattern but are not past-paper questions.

Showing 2621–2630 of 9654 questions

Browse by subject
RAS Prelims Science and Technology · Genetics, Biotechnology and Nanotechnology
Q2621. Match List-I with List-II regarding biotech products and their applications:
Biotech productMedical application
A. Tissue Plasminogen Activator (tPA)i. Treatment of diabetes mellitus
B. Erythropoietinii. Dissolving blood clots in stroke or heart attack patients
C. Interferonsiii. Stimulating red blood cell production in anemia
D. Humuliniv. Antiviral and anticancer therapies
RAS Prelims Science and Technology · Genetics, Biotechnology and Nanotechnology
Q2622. Gene therapy was first successfully applied clinically in 1990 to treat a four-year-old girl suffering from:
RAS Prelims Science and Technology · Genetics, Biotechnology and Nanotechnology
Q2623. Recombinant DNA technology has allowed the development of safer vaccines. The Hepatitis B vaccine is produced using:
RAS Prelims Science and Technology · Genetics, Biotechnology and Nanotechnology
Q2624. Which of the following is an advantage of genetically engineered antibiotics over traditional ones?
RAS Prelims Science and Technology · Genetics, Biotechnology and Nanotechnology
Q2625. Hybridoma technology is primarily used for the production of:
RAS Prelims Science and Technology · Genetics, Biotechnology and Nanotechnology
Q2626. Identify the incorrect statement regarding gene therapy.
RAS Prelims Science and Technology · Genetics, Biotechnology and Nanotechnology
Q2627. The process of analyzing a patient’s genetic profile to tailor medical treatments and drug dosages is known as:
RAS Prelims Science and Technology · Genetics, Biotechnology and Nanotechnology
Q2628. What is a key limitation of using retroviral vectors in gene therapy?
RAS Prelims Science and Technology · Genetics, Biotechnology and Nanotechnology
Q2629. Bioremediation is the use of living organisms, primarily microbes, to:
RAS Prelims Science and Technology · Genetics, Biotechnology and Nanotechnology
Q2630. Consider the following statements about bioremediation:
I. Pseudomonas putida is a genetically engineered superbug used for cleaning oil spills.
II. Bioremediation is generally more cost-effective and eco-friendly than chemical cleanup methods.
III. Heavy metals like lead and mercury can be easily completely destroyed by microbial bioremediation.
IV. Phytomining uses plants to extract precious metals from low-grade ores.
V. Ex-situ bioremediation involves treating contaminated soil at the site without removing it.
Which of the above statement(s) is/are correct?

Answer key for these questions

QCorrect answer
2621(a) A-ii, B-iii, C-iv, D-i
2622(d) Adenosine Deaminase (ADA) deficiency
2623(a) Yeast cells genetically engineered to produce the viral surface antigen
2624(b) Large-scale production and modification to combat bacteria
2625(b) Monoclonal antibodies
2626(a) Germline gene therapy is widely practiced globally and is free from ethical restrictions.
2627(c) Pharmacogenomics
2628(d) Random genomic integration triggering oncogenic changes
2629(b) Degrade or detoxify environmental pollutants
2630(a) I, II and IV

Frequently asked questions

How many RAS Prelims practice MCQs are there on RAS Prelims?

This page has 9654 practice MCQs on the RAS Prelims syllabus. Each has the correct answer, and most have an explanation.

How should I practise MCQs for RAS Prelims?

Attempt each question first, then open the answer and read the explanation. Practise one chapter at a time, note the facts you got wrong and revise them. Repeat the chapter after a few days.

Are these actual RAS Prelims past-paper questions?

No. These are practice questions written for the RAS Prelims syllabus. They follow the pattern the exam uses: factual questions, statement-based questions, match-the-list and assertion-reason.